Efficient infection of primitive hematopoietic stem cells by modified adenovirus

[1]  L. Rassenti,et al.  CD40-ligand (CD154) gene therapy for chronic lymphocytic leukemia. , 2000, Blood.

[2]  Z. Dai,et al.  The Dual Role of IL-2 in the Generation and Maintenance of CD8+ Memory T Cells1 , 2000, The Journal of Immunology.

[3]  R. Offringa,et al.  The role of CD40 in peripheral T cell tolerance and immunity , 2000, Journal of Molecular Medicine.

[4]  R. Crystal,et al.  Adenoviral vector-mediated gene transfer to primitive human hematopoietic progenitor cells: assessment of transduction and toxicity in long-term culture. , 2000, Blood.

[5]  S. Karlsson,et al.  Efficient adenoviral vector transduction of human hematopoietic SCID-repopulating and long-term culture-initiating cells. , 2000, Human gene therapy.

[6]  R. Finberg,et al.  Maturation and Lineage‐Specific Expression of the Coxsackie and Adenovirus Receptor in Hematopoietic Cells , 2000, Stem cells.

[7]  Sally R. M. Clarke,et al.  The critical role of CD40/CD40L in the CD4‐dependent generation of CD8+ T cell immunity , 2000, Journal of leukocyte biology.

[8]  G. Stamatoyannopoulos,et al.  Efficient Gene Transfer into Human CD34+ Cells by a Retargeted Adenovirus Vector , 2000, Journal of Virology.

[9]  A. Segerman,et al.  Adenovirus Types 11p and 35p Show High Binding Efficiencies for Committed Hematopoietic Cell Lines and Are Infective to These Cell Lines , 2000, Journal of Virology.

[10]  J. Kirkwood,et al.  Interleukin-2: developing additional cytokine gene therapies using fibroblasts or dendritic cells to enhance tumor immunity. , 2000, The cancer journal from Scientific American.

[11]  E. Schattner.  CD40 Ligand in CLL Pathogenesis and Therapy , 2000, Leukemia & lymphoma.

[12]  B. Quesnel,et al.  Transduction of bone marrow cells by the AdZ.F(pK7) modified adenovirus demonstrates preferential gene transfer in myeloma cells. , 1999, Human gene therapy.

[13]  D. Huhn,et al.  Phase I clinical study applying autologous immunological effector cells transfected with the interleukin-2 gene in patients with metastatic renal cancer, colorectal cancer and lymphoma , 1999, British Journal of Cancer.

[14]  B. Davidson,et al.  A Chimeric Type 2 Adenovirus Vector with a Type 17 Fiber Enhances Gene Transfer to Human Airway Epithelia , 1999, Journal of Virology.

[15]  F. Lemonnier,et al.  Analysis of T-cell defects in the specific immune response against acute lymphoblastic leukemia cells. , 1999, Experimental hematology.

[16]  D. Carlo,et al.  Interleukin 2 gene therapy of colorectal carcinoma with autologous irradiated tumor cells and genetically engineered fibroblasts: a Phase I study. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[17]  S. Spence,et al.  Redirected infection of directly biotinylated recombinant adenovirus vectors through cell surface receptors and antigens. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[18]  L. Naldini,et al.  Stable transduction of quiescent CD34(+)CD38(-) human hematopoietic cells by HIV-1-based lentiviral vectors. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[19]  S. Gallinger,et al.  Adenovector-mediated gene delivery of interleukin-2 in metastatic breast cancer and melanoma: results of a phase 1 clinical trial , 1999, Gene Therapy.

[20]  C. Verfaillie,et al.  Expression and function of cell adhesion molecules on fetal liver, cord blood and bone marrow hematopoietic progenitors: implications for anatomical localization and developmental stage specific regulation of hematopoiesis. , 1999, Experimental hematology.

[21]  W. Vainchenker,et al.  Lipofectamine and related cationic lipids strongly improve adenoviral infection efficiency of primitive human hematopoietic cells. , 1998, Human gene therapy.

[22]  P. Doherty,et al.  Thymic lymphoproliferative disease after successful correction of CD40 ligand deficiency by gene transfer in mice , 1998, Nature Medicine.

[23]  D. Brough,et al.  The Coxsackievirus-Adenovirus Receptor Protein Can Function as a Cellular Attachment Protein for Adenovirus Serotypes from Subgroups A, C, D, E, and F , 1998, Journal of Virology.

[24]  D. Campana,et al.  IL-2 adenovector-transduced autologous tumor cells induce antitumor immune responses in patients with neuroblastoma. , 1998, Blood.

[25]  JM Wilson,et al.  High throughput method for creating and screening recombinant adenoviruses , 1998, Gene Therapy.

[26]  J. Nolta,et al.  Engraftment and retroviral marking of CD34+ and CD34+CD38- human hematopoietic progenitors assessed in immune-deficient mice. , 1998, Blood.

[27]  R. Johnson,et al.  Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species , 1997, Nature Medicine.

[28]  T. Tötterman,et al.  Efficient adenovirus-mediated gene transduction of normal and leukemic hematopoietic cells , 1997, Gene Therapy.

[29]  M. Brenner,et al.  CD40 ligand induces an antileukemia immune response in vivo. , 1997, Blood.

[30]  J. Banchereau,et al.  Functions of CD40 on B cells, dendritic cells and other cells. , 1997, Current opinion in immunology.

[31]  M. Rollence,et al.  Selective targeting of human cells by a chimeric adenovirus vector containing a modified fiber protein , 1997, Journal of virology.

[32]  H. Ochs,et al.  Mutations of the CD40 ligand gene in 13 Japanese patients with X-linked hyper-IgM syndrome , 1997, Human Genetics.

[33]  R. Mentel,et al.  Adenovirus‐receptor interaction with human lymphocytes , 1997, Journal of medical virology.

[34]  J. Bergelson,et al.  Isolation of a Common Receptor for Coxsackie B Viruses and Adenoviruses 2 and 5 , 1997, Science.

[35]  T. Kipps,et al.  Adenovirus vector infection of chronic lymphocytic leukemia B cells. , 1996, Blood.

[36]  A. Ho,et al.  Retrovirus-mediated gene expression in hematopoietic cells correlates inversely with growth factor stimulation. , 1996, Human gene therapy.

[37]  David A. Williams,et al.  Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: Implications for gene therapy , 1996, Nature Medicine.

[38]  H. Fine,et al.  Selective transgene expression for detection and elimination of contaminating carcinoma cells in hematopoietic stem cell sources. , 1996, The Journal of clinical investigation.

[39]  D. Curiel,et al.  Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism , 1996, Journal of virology.

[40]  T. Meeker,et al.  Selective elimination (purging) of contaminating malignant cells from hematopoietic stem cell autografts using recombinant adenovirus. , 1996, Cancer gene therapy.

[41]  J. Gribben,et al.  Pre-B acute lymphoblastic leukemia cells may induce T-cell anergy to alloantigen. , 1996, Blood.

[42]  L. Leinwand,et al.  Adenovirus type 5 and 7 capsid chimera: fiber replacement alters receptor tropism without affecting primary immune neutralization epitopes , 1996, Journal of virology.

[43]  A. S. Conner,et al.  Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo , 1996, The Journal of experimental medicine.

[44]  G. Crooks,et al.  A functional comparison of CD34 + CD38- cells in cord blood and bone marrow. , 1995, Blood.

[45]  Ronald G. Crystal,et al.  Transfer of Genes to Humans: Early Lessons and Obstacles to Success , 1995, Science.

[46]  G. Nemerow,et al.  Upregulation of integrins alpha v beta 3 and alpha v beta 5 on human monocytes and T lymphocytes facilitates adenovirus-mediated gene delivery , 1995, Journal of virology.

[47]  H. Heslop,et al.  Production of genetically modified Epstein-Barr virus-specific cytotoxic T cells for adoptive transfer to patients at high risk of EBV-associated lymphoproliferative disease. , 1995, Journal of hematotherapy.

[48]  B. Ziegler,et al.  Phenotype analysis of hematopoietic CD34+ cell populations derived from human umbilical cord blood using flow cytometry and cDNA-polymerase chain reaction. , 1994, Blood.

[49]  J. Banchereau,et al.  Role of CD40 antigen and interleukin‐2 in T cell‐dependent human B lymphocyte growth , 1994, European journal of immunology.

[50]  J. Gribben,et al.  Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[51]  G. Nemerow,et al.  Integrins α v β 3 and α v β 5 promote adenovirus internalization but not virus attachment , 1993, Cell.

[52]  A. Fischer,et al.  CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM , 1993, Nature.

[53]  I. Stamenkovic,et al.  A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[54]  P. Boulanger,et al.  Human adenovirus-host cell interactions: comparative study with members of subgroups B and C , 1990, Journal of virology.

[55]  A. Miller,et al.  Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection , 1990, Molecular and cellular biology.

[56]  M. Toribio,et al.  lnterleukin-2-dependent autocrine proliferation in T-cell development , 1989, Nature.

[57]  M. Toribio,et al.  Interleukin-2-dependent autocrine proliferation in T-cell development. , 1989, Nature.